Amrize (AMRZ) Q4 2025 earnings review

Shareholder Returns Mask Operational Split

Amrize delivered a mixed Q4 where a massive capital return plan overshadowed soft topline results. While the Board authorized a $1B buyback and significant dividends (special + ordinary), Q4 revenue slid 0.4% YoY as a 12% collapse in Building Envelope sales erased gains in Materials. The residential housing slowdown is hitting harder than expected, crushing Envelope margins by 290bps. However, management is betting big on 2026, guiding for an acceleration to 8-11% EBITDA growth driven by infrastructure projects and 'ASPIRE' cost savings. The balance sheet is pristine (1.1x leverage), but the immediate operational reality is a tale of two segments: robust aggregates vs. a struggling residential roofing business.

๐Ÿ‚ Bull Case

Aggressive Capital Returns

Management is deploying its balance sheet strength (1.1x net leverage). The authorization of a $1B share repurchase program plus a combined $0.88/share dividend (special + ordinary) signals high confidence in cash flow durability despite current market chop.

Building Materials Resilience

The core Materials segment remains robust. Segment Adjusted EBITDA grew 6% YoY in Q4 with margin expansion of 60bps (to 32.6%). Aggregates pricing power persists (+3.9% freight-adjusted), and volumes grew across both cement and aggregates.

๐Ÿป Bear Case

Building Envelope Breakdown

The diversification thesis failed this quarter. Building Envelope revenue plunged nearly 12%, and EBITDA collapsed 23.5%. Reliance on the residential roofing market (soft demand + milder storm season) is a significant drag on consolidated performance.

Loss of Cement Pricing Power

Unlike Aggregates, Cement pricing has stalled. Cement price per ton was slightly negative (-0.2% YoY) in Q4. If infrastructure demand cannot support price hikes, the 2026 margin expansion targets rely entirely on cost cuts rather than commercial leverage.

โš–๏ธ Verdict: โšช

Neutral. The capital return plan is excellent, and the 2026 guidance is optimistic. However, the operational deterioration in Building Envelope and the loss of pricing power in Cement are immediate red flags that make the 'acceleration' narrative a show-me story.

Key Themes

CONCERNNEW๐Ÿ”ด๐Ÿ”ด

Building Envelope Margin Compression

Decelerating. The Building Envelope segment is facing a severe correction. Revenue fell 11.8% and Adjusted EBITDA margin compressed 290bps to 19.2%. Management cites 'softer residential roofing demand' and an $8M increase in warranty provisions. This segment has turned from a growth driver into a margin diluter.

DRIVER๐ŸŸข

Aggregates Pricing Power

Stable/Positive. While Cement pricing flatlined, Aggregates continues to carry the load. Freight-adjusted pricing rose 3.9% YoY in Q4, with volumes up 3.0%. This pricing power is critical for the FY26 guidance, which assumes mid-single-digit pricing growth in aggregates.

DRIVERNEWโšช

West Texas M&A Expansion

Management announced the acquisition of PB Materials, a leading aggregates provider in West Texas with >50 years of reserves and $180M in revenue. Expected to close in Q1 2026, this deal aligns with the strategy to pivot toward high-growth infrastructure markets and leverage the clean balance sheet.

CONCERN๐Ÿ”ด

Cash Flow Efficiency Decline

Reversing. Free Cash Flow for FY25 ended at $1.46B, down significantly from $1.73B in FY24 (-15%). Cash conversion fell to 49% from 54%. While working capital headwinds were mentioned, the divergence between Net Income (-7%) and FCF (-15%) bears monitoring as CapEx ramps up to $900M in 2026.

THEMEโšช

ASPIRE Cost Savings

Management claims initial savings from the ASPIRE program were realized in Q4. They are targeting 70bps of margin expansion in 2026 specifically from this program. Given the pricing pressure in cement, hitting these efficiency targets is non-negotiable for meeting FY26 EBITDA guidance.

CONCERNNEW๐Ÿ”ด

Warranty Provision Spike

A specific $8 million increase in warranty provisions was flagged in the Building Envelope segment. While not a massive absolute number, in the context of falling segment sales, this suggests potential quality control or product mix issues that could persist.

Other KPIs

Net Leverage Ratio1.1x

Significantly below the <1.5x target, providing ample room for the $1B buyback program and the PB Materials acquisition without stressing the balance sheet.

FY25 Net Income$1.18 Billion

Decelerating. Down 7.1% YoY from $1.27B in FY24. Margins compressed 90bps to 10.0%. The decline reflects higher interest expenses (net $413M vs $512M prior year, though improved) failing to offset operational softness.

Annual Dividend (Special + Ordinary)$0.88 per share

New Catalyst. The Board proposed a special one-time dividend of $0.44 plus an ordinary annual dividend of $0.44. This substantial cash return is a key sweetener for investors waiting for the operational turnaround.

Guidance

FY26 Revenue$12.29B - $12.52B

Accelerating. Implies +4% to +6% growth, a distinct improvement over the +0.9% achieved in FY25. Assumes recovery in residential roofing H2 and continued infrastructure strength.

FY26 Adjusted EBITDA$3.25B - $3.34B

Accelerating. Implies +8% to +11% growth. This is aggressive compared to the -5.5% decline seen in FY25. Success relies heavily on 70bps of ASPIRE margin expansion and mid-single digit aggregates pricing.

FY26 Capital Expenditures$900 Million

Increasing. Up from $788M in FY25. The company is spending heavily on capacity (Ste. Genevieve, Malarkey plant) despite the current earnings lull.

FY26 Building Envelope OutlookResi Flat, Comm Low-Single Digit

Stabilizing. Management expects residential volumes to be flat (improving in H2) and commercial to grow low-single digits. This is a low bar to clear after the double-digit declines in Q4.

Key Questions

Cement Pricing Dynamics

Cement pricing was negative (-0.2%) in Q4 while Aggregates rose nearly 4%. What specific market dynamics are suppressing cement pricing, and what gives confidence in the 'low single-digit' growth guidance for 2026?

Residential Recovery Visibility

Building Envelope revenue dropped ~12% in Q4. The 2026 guidance assumes improvement in H2. What leading indicators (orders, distributor inventory) support this view vs. a prolonged downturn?

Warranty Provision Details

Can you elaborate on the $8M warranty provision increase in Building Envelope? Is this related to a specific product line or vintage, and is the risk ring-fenced?

Cost Savings vs. Inflation

You target 70bps margin expansion from ASPIRE. How much of this is net of underlying inflation, particularly given the wage and energy pressure seen in the sector?